The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 00173/0046.
12.0% w/w salicylic acid, 4.0% w/w lactic acid, gel
Keep this leaflet. You may need to read it again.
Ask your doctor or pharmacist if you need more information or advice.
1. What Salatac Gel is and what it is used for
2. Before you use Salatac Gel
3. How to use Salatac Gel
4. Possible side effects
5. How to store Salatac Gel
6. Further information
Do not use Salatac Gel if you are allergic (hypersensitive) to salicylic acid, lactic acid or any of the other ingredients of Salatac Gel listed in Section 6.
Take special care when using this product:
This product is not known to affect, or to be affected by any other medicines.
This product can be used during pregnancy and while breast feeding. The ingredients have been in widespread use in this and similar preparations for many years, without reports of problems. However, safety trials have not been conducted.
Using this product is not known to affect your ability to drive or use machinery.
Use it only on warts, verrucas, corns and calluses on sites for which it is recommended.
To use the gel (adults, children and the elderly):
Follow these steps once every day, usually in the evening. Carry on using the gel in this way until the wart, verruca, corn or callus disappears:
A. Soak the affected area in warm water for 2 to 3 minutes.
B. Dry the area thoroughly, using your own towel if you have a wart or verruca (this will help stop the infection spreading to other people).
C. Taking care to avoid squeezing the tube, remove the protective cap, leaving the nozzle attached to the tube.
D. Carefully apply a thin coating (one or two drops) of the gel to the top of the wart, verruca, corn or callus only:
E. The next evening, carefully peel or pick off the white patch of dried gel from the wart, verruca, corn or callus:
F. Once every week, before applying fresh gel, gently rub the wart, verruca, corn or callus with the emery board provided, or a pumice stone:
G. The length of treatment will vary depending on the size and resistance of the wart, verruca, corn or callus:
H. At the end of treatment, if the white patch is difficult to remove, you can leave it because it will eventually fall off by itself.
If the gel accidentally gets onto normal skin, wipe it off straight away with a tissue, and, if necessary, wash the area.
If the gel accidentally gets into the eyes or mouth, it may cause damage. Rinse the eyes or mouth with plenty of water. If rinsing one eye, take care to avoid washing product into the other eye. Then seek urgent hospital attention.
If you inhale a lot of the vapour from the gel it may make you feel light-headed. If this happens, get plenty of fresh air.
Do not worry if you occasionally forget to use this product, just carry on using it when you remember.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Salatac Gel can cause side effects although not everybody gets them:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.
The active ingredients are salicylic acid (12.0% w/w) and lactic acid (4.0% w/w).
The other ingredients are camphor, pyroxylin, ethanol and ethyl acetate.
The product is a clear colourless gel.
The product is available in a tube containing 8 g of gel. The tube has a special applicator nozzle. Each pack also includes an emery board.
This Leaflet was last revised in April 2021.
To listen to or request a copy of this leaflet in Braille, large print or audio, please call free of charge: 0800 198 5000 (UK only).
Please be ready to give the following information: Salatac Gel, 00173/0046.
This is a service provided by the Royal National Institute of Blind People (RNIB).
Salatac PIL WP4_21_1.indd